Free Trial
NASDAQ:CLBT

Cellebrite DI (CLBT) Stock Price, News & Analysis

Cellebrite DI logo
$16.55 +0.08 (+0.47%)
As of 09:31 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Cellebrite DI Stock (NASDAQ:CLBT)

Key Stats

Today's Range
$16.55
$16.55
50-Day Range
$13.52
$16.47
52-Week Range
$13.10
$26.30
Volume
1,143 shs
Average Volume
1.66 million shs
Market Capitalization
$3.96 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.40
Consensus Rating
Buy

Company Overview

Cellebrite DI Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
66th Percentile Overall Score

CLBT MarketRank™: 

Cellebrite DI scored higher than 66% of companies evaluated by MarketBeat, and ranked 289th out of 664 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cellebrite DI has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Cellebrite DI has only been the subject of 2 research reports in the past 90 days.

  • Read more about Cellebrite DI's stock forecast and price target.
  • Earnings Growth

    Earnings for Cellebrite DI are expected to grow by 20.00% in the coming year, from $0.30 to $0.36 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cellebrite DI is -21.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cellebrite DI is -21.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Cellebrite DI has a PEG Ratio of 2.87. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Cellebrite DI has a P/B Ratio of 9.63. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Cellebrite DI's valuation and earnings.
  • Percentage of Shares Shorted

    3.33% of the float of Cellebrite DI has been sold short.
  • Short Interest Ratio / Days to Cover

    Cellebrite DI has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cellebrite DI has recently increased by 8.04%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Cellebrite DI does not currently pay a dividend.

  • Dividend Growth

    Cellebrite DI does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.33% of the float of Cellebrite DI has been sold short.
  • Short Interest Ratio / Days to Cover

    Cellebrite DI has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cellebrite DI has recently increased by 8.04%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Cellebrite DI has a news sentiment score of 1.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.94 average news sentiment score of Computer and Technology companies.
  • News Coverage This Week

    MarketBeat has tracked 10 news articles for Cellebrite DI this week, compared to 6 articles on an average week.
  • Search Interest

    Only 4 people have searched for CLBT on MarketBeat in the last 30 days. This is a decrease of -43% compared to the previous 30 days.
  • MarketBeat Follows

    Only 3 people have added Cellebrite DI to their MarketBeat watchlist in the last 30 days. This is a decrease of -40% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cellebrite DI insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.70% of the stock of Cellebrite DI is held by insiders.

  • Percentage Held by Institutions

    45.88% of the stock of Cellebrite DI is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Cellebrite DI's insider trading history.
Receive CLBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellebrite DI and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CLBT Stock News Headlines

Craig-Hallum Reiterates a Buy Rating on Cellebrite DI Ltd. (CLBT)
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.tc pixel
See More Headlines

CLBT Stock Analysis - Frequently Asked Questions

Cellebrite DI's stock was trading at $22.03 on January 1st, 2025. Since then, CLBT stock has decreased by 25.2% and is now trading at $16.47.

Cellebrite DI Ltd. (NASDAQ:CLBT) announced its quarterly earnings data on Thursday, August, 14th. The company reported $0.12 EPS for the quarter, beating analysts' consensus estimates of $0.11 by $0.01. The company's quarterly revenue was up 18.4% on a year-over-year basis.
Read the conference call transcript
.

Top institutional shareholders of Cellebrite DI include Voss Capital LP (2.15%), Clal Insurance Enterprises Holdings Ltd (1.63%), Invesco Ltd. (1.46%) and Pertento Partners LLP (1.23%).

Shares of CLBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cellebrite DI investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), TotalEnergies (TTE) and Southern First Bancshares (SFST).

Company Calendar

Last Earnings
8/14/2025
Today
8/28/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
INTERNET SOFTWARE
Sub-Industry
Computer Software
Current Symbol
NASDAQ:CLBT
CIK
1854587
Employees
1,167
Year Founded
N/A

Price Target and Rating

High Price Target
$25.00
Low Price Target
$18.00
Potential Upside/Downside
+36.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.76)
Trailing P/E Ratio
N/A
Forward P/E Ratio
54.90
P/E Growth
2.87
Net Income
-$283.01 million
Net Margins
-34.56%
Pretax Margin
-33.09%
Return on Equity
23.92%
Return on Assets
11.94%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.96
Quick Ratio
1.92

Sales & Book Value

Annual Sales
$401.20 million
Price / Sales
9.83
Cash Flow
$0.38 per share
Price / Cash Flow
43.26
Book Value
$1.71 per share
Price / Book
9.63

Miscellaneous

Outstanding Shares
239,470,000
Free Float
225,820,000
Market Cap
$3.94 billion
Optionable
Optionable
Beta
1.27

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:CLBT) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners